Download PDF
Dtsch Med Wochenschr 2003; 128: S36-S50
DOI: 10.1055/s-2003-39116
Aus Fachgremien & Konsensuskonferenzen
© Georg Thieme Verlag Stuttgart · New York

Deutsch-Österreichische Leitlinien zur postexpositionellen Prophylaxe der HIV-Infektion

(Aktualisierung Mai 2002)Post-exposure prophylaxis of HIV infection. German-Austrian guidelines(May 2002)
Further Information

Publication History

Publication Date:
08 May 2003 (online)

Also available at
   Permissions and Reprints
Preview

Einleitung

Angesichts der Übertragbarkeit einer HIV-Infektion mit hoher Morbidität und Mortalität wurde international seit 1989 bei Gefahr einer Infektion im beruflichen Alltag die postexpositionelle Einnahme von Zidovudin empfohlen und vielfach praktiziert [1] [2]. Inzwischen liegen deutliche Hinweise auf eine Wirksamkeit dieser Prophylaxe nach beruflicher Exposition vor [3] [4]. Auch zur Vermeidung der vertikalen Übertragung einer HIV-Infektion konnte die Wirksamkeit überzeugend nachgewiesen werden [5].

Auf einer Konsensuskonferenz der Deutschen und Österreichischen AIDS-Gesellschaft sowie des Robert Koch-Institutes im Februar 2002 wurde eine Aktualisierung der Empfehlungen von 1998 [6] dieser Gesellschaften und Organisationen diskutiert und beschlossen. Ziel der nun aktualisierten, ausführlichen Empfehlungen ist es weiterhin, auf der Grundlage des erweiterten Wissensstandes und der veränderten Therapieoptionen konkrete Handlungsanleitungen zu geben und alle in die Entscheidungen einbezogenen Ärztinnen und Ärzte in die Lage zu versetzen, die Indikation zu einer HIV-Postexpositionsprophylaxe zu stellen, diese durchzuführen und die betroffenen Personen kompetent zu beraten.

Literatur

  • 1 Centers for disease control . Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis.  MMWR. 2001;  50 1-41
    Search in Google Scholar
  • 2 Gerberding J L. Is antiretroviral treatment after percutaneous HIV exposure justified?.  Ann Intern Med. 1993;  118 979-80
    Search in Google Scholar
  • 3 Henderson D K, Gerberding J L. Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis.  J Infect Dis. 1989;  160 321-327
    Search in Google Scholar
  • 4 Cardo D M, Culver D H, Ciesielski C A. et al . A case-control study of HIV seroconversion in health care workers after percutaneous exposure to HIV-infected blood: clinical and public health implications.  N Engl J Med. 1997;  337 1485-1490
    Search in Google Scholar
  • 5 Centers for disease control . Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994.  MMWR Morbidity & Mortality Weekly Report. 1995;  44 929-933
    Search in Google Scholar
  • 6 Lallemant M, Jourdain G, le Coeur S. et al . A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1.  N Engl J Med. 2000;  343 982-991
    Search in Google Scholar
  • 7 Postexpositionelle Prophylaxe nach HIV-Exposition. Deutsch-Österreichische Empfehlungen.  Dtsch Med Wochenschr. 1998;  123 4-16
    Search in Google Scholar
  • 8 Lafon S W, Mooney B D, McMullen J P. et al .A double-blind, placebo-controlled study of the safety and efficacy of retrovir® (zidovudine, ZDV) as a chemoprophylactic agent in health care workers exposed to HIV (Abstr. 489). 30th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta 1990
    Search in Google Scholar
  • 9 Katz M H, Gerberding J L. Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use.  N Engl J Med. 1997;  336 1097-1100
    Search in Google Scholar
  • 10 Van Rompay K K, Marthas M L, Ramos R A. et al . Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviral drug prophylaxis and therapy: oral 3-azido-3-deoxythymidine prevents SIV infection.  Antimicrob Agents Chemother. 1992;  36 2381-2386
    Search in Google Scholar
  • 11 Mathes L E, Polas P J, Hayes K A, Swenson C L, Johnson S, Kociba G J. Pre- and postexposure chemoprophylaxis: evidence that 3’-azido-3’dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response.  Antimicrob Agents Chemother. 1992;  36 2715-2721
    Search in Google Scholar
  • 12 Martin I N, Murphey-Corb M, Soike K F, Davison-Fairburn B, Baskin G B. Effects of initiation of 3’-azido,3’-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus.  J Infect Dis. 1993;  168 825-835
    Search in Google Scholar
  • 13 Tsai C C, Follis K E, Grant R F. et al . Effect of dosing frequency on ZDV prophylaxis in macaques infected with simian immunodeficiency virus.  J AIDS. 1993;  6 1086-1092
    Search in Google Scholar
  • 14 Ruprecht R M, Bronson R. Chemoprevention of retroviral infection: success is determined by virus inoculum strength and cellular immunity.  DNA Cell Biol. 1994;  13 59-66
    Search in Google Scholar
  • 15 Tsai C -C, Follis K E, Sabo A. et al . Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl) adenine.  Science. 1995;  270 1197-1199
    Search in Google Scholar
  • 16 Böttiger D, Johansson N -G, Samuelsson B. et al . Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005.  AIDS. 1997;  11 157-162
    Search in Google Scholar
  • 17 Tsai C -C, Emau P, Follis K E. et al . Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment.  J Virol. 1998;  72 4265-4273
    Search in Google Scholar
  • 18 Van Rompay K KA, Dailey P J, Tarara R P. et al . Early short-term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine treatment favourably alters the subsequent disease course in simian immunodeficiency virus-infected newborn rhesus macaques.  J Vir. 1999;  73 2947-2955
    Search in Google Scholar
  • 19 Hodge S, de Rosayro J, Glenn A. et al . Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj.  J Vir. 1999;  73 863 039
    Search in Google Scholar
  • 20 Lifson J D, Rossio J L, Arnaout R. et al . Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.  J Vir. 2000;  74 2584-2593
    Search in Google Scholar
  • 21 Mori K, Yasutomi Y, Sawada S. et al . Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.  J Vir. 2000;  74 5747-5753
    Search in Google Scholar
  • 22 Otten R A, Smith D K, Adams D R. et al . Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2).  J Virol. 2000;  74 9771-9775
    Search in Google Scholar
  • 23 Van Rompay K KA, Miller M D, Marthas M L. et al . Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(Phosphonomethoxy)Propyl]Adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPA.  J Vir. 2000;  74 1767-1774
    Search in Google Scholar
  • 24 Pinto L A, Landay A L, Berzofsky J A, Kessler H A, Shearer G M. Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood.  Am J Med. 1997;  102 21-24 (suppl 5B)
    Search in Google Scholar
  • 25 Downs A M, de Vincenzi I. European Study Group in Heterosexual Transmission of HIV . Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts.  Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 1996;  11 388-395
    Search in Google Scholar
  • 26 Degruttola V, Seage G R, Mayer K H, Horsburgh C R. Infectiousness of HIV between male homosexual partners.  Journal of Clinical Epidemiology. 1989;  42 849-856
    Search in Google Scholar
  • 27 Peterman T A, Stoneburner R L, Allen J R, Jaffe H W, Curran J W. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections.  JAMA. 1988;  259 55-58
    Search in Google Scholar
  • 28 Royce R A, Sena A, Cates W, Cohen M S. Sexual contact and transmission of HIV.  N Engl J Med. 1997;  336 1072-1078
    Search in Google Scholar
  • 29 Mastro T D, Satten G A, Nopkesorn T. et al . Probability of female-to-male transmission of HIV-1 in Thailand.  Lancet. 1994;  343 204-207
    Search in Google Scholar
  • 30 Henderson D K, Fahey B J, Willy M, Schmitt J M, Carey K, Koziol D E, Lane H C, Fedio J, Saah A J. Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation.  Ann Intern Med. 1990;  113 740-746
    Search in Google Scholar
  • 31 Ippolito G, Puro V, De Carli G. Italian Study Group on Occupational Risk of HIV Infection . The risk of occupational human immunodeficiency virus in health care workers.  Arch Int Med. 1993;  153 1451-1458
    Search in Google Scholar
  • 32 Gerberding  JL. Prophylaxis for occupational exposure to HIV.  Annals of Internal Medicine. 1996;  125 497-501
    Search in Google Scholar
  • 33 Liuzzi G, Chirianni A, Clementi M, Bagnarelli P, Valenza A, Cataldo P T. et al . Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study.  AIDS. 1996;  10 F51-56
    Search in Google Scholar
  • 34 Rasheed S, Li Z, Xu D, Kovacs A. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.  Am J Obstet Gynecol. 1996;  175 122-129
    Search in Google Scholar
  • 35 Vernazza P L, Kashuba A DM, Cohen M S. Biological correlates of sexual transmission of HIV. Practical consequences and potential targets for Public Health.  Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2002;  45 277-285
    Search in Google Scholar
  • 36 Daar E S, Moudgil T, Meyer R D, Ho D D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection.  N Engl J Med. 1991;  324 961-964
    Search in Google Scholar
  • 37 HO D D, Moudgil T, Alarn M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.  N Engl J Med. 1989;  321 1621-1625
    Search in Google Scholar
  • 38 Weiss S H, Saxinger W C, Rechtman D. et al . Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers.  Science. 1988;  239 68-71
    Search in Google Scholar
  • 39 Centers for Disease Control . Surveillance for occupationally acquired HIV infection - United States, 1981-1992.  MMWR Morb Mortal Wkly Rep. 1992;  41 823-825
    Search in Google Scholar
  • 40 Katzenstein T L, Dickmeiss E, Aladdin H, Hede A. et al . Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.  Ann Intern Med. 2000;  133 31-34
    Search in Google Scholar
  • 41 Lange J M. Failure of zidovudine prophylaxis after accidental exposure to HIV-1.  N Engl J Med. 1990;  322 1375-1377
    Search in Google Scholar
  • 42 Looke D F, Growe D I. Failed prophylactic zidovudine after needlestick injury.  Lancet. 1990;  335 1280
    Search in Google Scholar
  • 43 Beltrami E M, Luo C -C, Dela Torre N, Cardo D M. HIV transmission after an occupational exposure despite postexposure prophylaxis with a combination drug regimen (Abstr.). 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections in conjunction with the 10th Annual Meeting of SHEA, Atlanta 2000: S2-62
    Search in Google Scholar
  • 44 Durand E, Le J eune C, Hugues F C. Failure of prophylactic zidovudine after suicidal self-inoculation of HIV-infected blood.  N Engl J Med. 1991;  324 1062
    Search in Google Scholar
  • 45 Jochimsen E M. Failures of zidovudine postexposure prophylaxis.  Am J Med. 1997;  102 52-55 (suppl 5B)
    Search in Google Scholar
  • 46 Jones P D. HIV transmission by stabbing despite zidovudine prophylaxis.  Lancet. 1991;  338 884
    Search in Google Scholar
  • 47 Perdue B, Wolderufael D, Mellors J, Quinn T, Margolick J. HIV-1 transmission by a needlestick injury despite rapid initiation of four-drug postexposure prophylaxis (Abstr. 210). 6th Conference on Retroviruses and Opportunistic Infections, Chicago 1999
    Search in Google Scholar
  • 48 Martin J N, Roland M E, Bamberger J D. et al .Postexposure prophylaxis after sexual or drug use exposure to HIV: final results from the San Francisco Post-Exposure Prevention (PEP) Project (Abstr. 196). 7th Conference on Retroviruses and Opportunistic Infections, San Francisco 2000
    Search in Google Scholar
  • 49 Schechter M, Lago R F, Ismerio R, Mendelsohn A B, Harrison l H. Acceptability, behavioral impact, and possible efficacy of post-sexual-exposure chemoprophylaxis (PEP) for HIV (Abstr. 15). 9th Conference on Retroviruses and Opprtunistic Infections, Seattle 2002
    Search in Google Scholar
  • 50 Letvin N. Immunopathogenesis of primate immunodeficiency virus interactions. 5th Conference on Retroviruses, Chicago 1998: L3
    Search in Google Scholar
  • 51 Zhang Z -Q. et al .Initial productive infection and cell tropisms in acute infection of rhesus monkeys with intravaginal inoculation of an uncloned sivmac 251 (Abstr. 277). 5th Conference on Retroviruses, Chicago 1998
    Search in Google Scholar
  • 52 Wang S A, Panlilio A L, Doi P A. et al . Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV postexposure prophylaxis registry.  Infect Control Hosp Epidemiol. 2000;  21 780-785
    Search in Google Scholar
  • 53 PURO V, Ippolito G, Guzzanti E. et al . Zidovudine prophylaxis after accidental exposure to HIV: the Italian experience.  AIDS. 1992;  6 963-969
    Search in Google Scholar
  • 54 Parkin J M, Murphy M, Anderson J, El-Gadi S, Forster G, Pinching A J. Tolerability and side-effects of post-exposure prophylaxis for HIV infection (Letter).  Lancet. 2000;  355 722-723
    Search in Google Scholar
  • 55 Centers for disease control . Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures-worldwide, 1997-2000.  MMWR. 2001;  49 1153-1156
    Search in Google Scholar
  • 56 Johnson S, Baraboutis J G, Sha B E, Proia L A, Kessler H A. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers (Letters).  JAMA. 2000;  284 2722-2723
    Search in Google Scholar
  • 57 Struble K A, Pratt R D, Gitterman S R. Toxicity of antiretroviral agents.  Am J Med. 1997;  102 65-67 (suppl 5B)
    Search in Google Scholar
  • 58 Food and Drug Administration . Protease inhibitors may increase blood glucose in HIV patients.  FDA Medical Bulletin. 1997;  27 2
    Search in Google Scholar
  • 59 Blanche S, Tardieu M, Rustin P. et al . Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues.  Lancet. 1999;  354 1084-1089
    Search in Google Scholar
  • 60 Centers for disease control . Public Health Service (PHS) Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and reducing perinatal HIV-1 transmission in the United States.  MMWR Morbidity & Mortality Weekly Report. 1998;  47 (RR-2)
    Search in Google Scholar
  • 61 Food and Drug Administration .Important drug warning. Accessed May 9 Available at <//www.fda.gov/medwatch/safety/2001/zerit&videx_letter.htm> 2001
    Search in Google Scholar
  • 62 Smith M E. US Nucleoside Safety Review Working Group .Ongoing nucleoside safety review of HIV exposed children in US studies (Abstr. 96). Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants, Montreal 1999
    Search in Google Scholar
  • 63 Centers for disease control . Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers.  MMWR. 1989;  38 6
    Search in Google Scholar
  • 64 Gerberding J L. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study.  J Infect Dis. 1994;  170 1410-1417
    Search in Google Scholar
  • 65 Gerberding J L. Management of occupational exposures to blood-borne viruses.  N Engl J Med. 1995;  332 444-451
    Search in Google Scholar
  • 66 Vittinghoff E, Buchbinder S P, Judson F, Douglas J, McKirnan D, MacQueen K. Per-contact risk for transmission of HIV associated with four types of homosexual contact (Abstr. 140). 5th Conference on Retroviruses and Opportunistic Infections, Chicago 1998
    Search in Google Scholar
  • 67 Gray R H, Wawer M J, Brookmeyer R. et al . Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda.  Lancet. 2001;  357 1149-1153
    Search in Google Scholar
  • 68 Fideli Ü S, Allen S A, Musonda R. et al . Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa.  AIDS Res and Hum Retroviruses. 2001;  17 901-910
    Search in Google Scholar
  • 69 Samuel M C, Mohr M S, Speed T P, Winkelstein W. Infectivity of HIV by anal and oral intercourse among homosexual men. New York: Raven In: Kaplan EH, Brandeau ML, eds. Modeling the AIDS Epidemic: Planning, Policy, and Prediction 1994: 423-438
    Search in Google Scholar
  • 70 Wiley J A, Herschkorn S J, Padian N S. Heterogeneity in the probability of HIV transmission per sexual contact: the case of male-to-female transmission in penile-vaginal intercourse.  Statistics in Medicine. 1989;  8 93-102
    Search in Google Scholar
  • 71 Lifson A R, O’Malley P M, Hessol N A, Buchbinder S P, Cannon L, Rutherford G W. HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices.  Am J Public Health. 1990;  80 1509-1511
    Search in Google Scholar
  • 72 Del Romero J, Marincovich B, Castilla J. et al . Evaluating the risk of HIV transmission through unprotected orogenital sex.  AIDS. 2002;  19 1296-1297
    Search in Google Scholar
  • 73 Kaplan E H, Heimer R. A model-based estimate of HIV infectivity via needle sharing.  J Acquir Immune Defic Syndr. 1992;  5 1116-1118
    Search in Google Scholar
  • 74 Montella F, Di Sora F, Recchia O. Can HIV-1 infection be transmitted by a „discarded” syringe?.  Journal of Acquired Immune Deficiency Syndrome. 1992;  5 1274-1275
    Search in Google Scholar
  • 75 Rinaldi R, Francavilla E, CadrobbI P, Bortolotti F. HIV infection and needle-stick injuries with syringes discarded by drug abusers.  Infection. 1991;  19 57
    Search in Google Scholar
  • 76 Panel on Clinical Practices for Treatment of HIV Infection .Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at <//hivatis.org/trtgdlns.html>
  • 77 Deutsche AIDS Gesellschaft (DAIG) .Konsensusempfehlung zur Therapie der HIV-Infektion, Aktualisierung Mai 2002. http://www.rki.de/INFEKT/AIDS_STD/BR_LINIE/BR_LINIE.HTM
  • 78 Guay L A, Musoke P, Fleming T. et al . Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.  Lancet. 1999;  354 795-802
    Search in Google Scholar
  • 79 Musoke P, Guay L A, Bagenda D. et al . A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).  AIDS. 1999;  13 479-486
    Search in Google Scholar
  • 80 Flexner C W. Principles of clinical pharmacology in postexposure prophylaxis.  Am J Med. 1997;  102 32-38 (suppl 5B)
    Search in Google Scholar
  • 81 BMS .Warning Letter vom 5.Januar 2001. 2001
    Search in Google Scholar
  • 82 Noor M A. et al . Metabolic effects of indinavir in healthy HIV-seronegative men.  AIDS. 2001;  15 11-18
    Search in Google Scholar
  • 83 Deeks S G, Smith M, Holodniy M, Kahn J O. HIV-1 protease inhibitors. A review for clinicians.  JAMA. 1997;  277 145-53
    Search in Google Scholar
  • 84 Centers for disease control . Sexually transmitted diseases treatment guidelines 2002.  MMWR Morbidity & Mortality Weekly Report. 2002;  51 RR6
    Search in Google Scholar
  • 85 Ciesielski C A, Metler R P. Duration of time between exposure and seroconversion in healthcare workers with occupationally acquired infection with human immunodeficiency virus.  Am J Med. 1997;  102 115-116 (suppl 5B)
    Search in Google Scholar
  • 86 Busch M P, Satten G A. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure.  Am J Med. 1997;  102 117-124 (suppl 5B)
    Search in Google Scholar
  • 87 Pinkerton S D, Holtgrave D R, Bloom F R. Postexposure treatment of HIV.  N Engl J Med. 1997;  337 500-501
    Search in Google Scholar
  • 88 Pinkerton S D, Holtgrave D R, Pinkerton H J. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.  Arch Intern Med. 1997;  157 1972-1980
    Search in Google Scholar

Prof. Dr. N. H. Brockmeyer

Klinik für Dermatologie und Allergologie der Ruhr Universität

Gudrunstr. 56

44791 Bochum

Phone: 0234-509 3471

Fax: 0234-509 3472